1,293 views
Alnylam is a pioneer in RNAi therapeutics, an innovative medicine that can "silence" specific genes that cause disease. As a world-class biotechnology company, we boldly challenge preconceived notions that are impossible or unrealistic, and bring about a revolution in the lives of Japanese patients who have limited treatment options. For more information, please visit alnylam.jp. CORP-JPN-00036